dalteparin has been researched along with Vitreoretinopathy, Proliferative in 2 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Vitreoretinopathy, Proliferative: Vitreoretinal membrane shrinkage or contraction secondary to the proliferation of primarily retinal pigment epithelial cells and glial cells, particularly fibrous astrocytes, followed by membrane formation. The formation of fibrillar collagen and cellular proliferation appear to be the basis for the contractile properties of the epiretinal and vitreous membranes.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Intraoperative bleeding, postoperative fibrin, hyphema and vitreous hemorrhage were graded in an unmasked fashion using previously described grading scales." | 3.73 | A prospective, open-label, dose-escalating study of low molecular weight heparin during repeat vitrectomy for PVR and severe diabetic retinopathy. ( Jumper, JM; Lane, RG; MacCumber, MW; McCuen, BW; Nasir, MA, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lane, RG | 1 |
| Jumper, JM | 1 |
| Nasir, MA | 1 |
| MacCumber, MW | 1 |
| McCuen, BW | 1 |
| Schaub, F | 1 |
| Schiller, P | 1 |
| Hoerster, R | 1 |
| Kraus, D | 1 |
| Holz, FG | 1 |
| Guthoff, R | 1 |
| Agostini, H | 1 |
| Spitzer, MS | 1 |
| Wiedemann, P | 1 |
| Lommatzsch, A | 1 |
| Boden, KT | 1 |
| Dimopoulos, S | 1 |
| Bemme, S | 1 |
| Tamm, S | 1 |
| Maier, M | 1 |
| Roider, J | 1 |
| Enders, P | 1 |
| Altay, L | 1 |
| Fauser, S | 1 |
| Kirchhof, B | 1 |
1 trial available for dalteparin and Vitreoretinopathy, Proliferative
| Article | Year |
|---|---|
Intravitreal 5-Fluorouracil and Heparin to Prevent Proliferative Vitreoretinopathy: Results from a Randomized Clinical Trial.
Topics: Dalteparin; Double-Blind Method; Fluorouracil; Heparin; Heparin, Low-Molecular-Weight; Humans; Retin | 2022 |
1 other study available for dalteparin and Vitreoretinopathy, Proliferative
| Article | Year |
|---|---|
A prospective, open-label, dose-escalating study of low molecular weight heparin during repeat vitrectomy for PVR and severe diabetic retinopathy.
Topics: Diabetic Retinopathy; Enoxaparin; Female; Fibrin; Fibrinolytic Agents; Humans; Hyphema; Infusion Pum | 2005 |